Understanding the New TGA & Ahpra Guidelines for Injectable Treatments in Australia
Australia’s cosmetic injectable industry is undergoing significant regulatory changes designed to improve patient safety, transparency, and ethical advertising.
The updated guidance from Ahpra and the Therapeutic Goods Administration (TGA) affects how cosmetic injectable services can be advertised, prescribed, and delivered across Australia.
Why the Rules Are Changing
Regulators introduced these changes in response to concerns about:
- Misleading advertising
- Inadequate consultation practices
- Social media promotion targeting young people
- Insufficient practitioner training and supervision
- Unsafe prescribing models
The reforms aim to ensure patients receive medically appropriate care, informed consent, and realistic expectations before treatment.
Key Changes Patients Should Know
1. Stricter Advertising Rules
Because most cosmetic injectables are prescription-only medicines in Australia, we cannot directly or indirectly advertise these products to the public.
This means we avoid:
- Mentioning prescription product names
- Using terms that imply prescription injectables
- Before-and-after imagery that may be misleading
- Promotions, discounts, or inducements
- Testimonials relating to clinical outcomes
- Advertising directed at people under 18
Instead, we focus on education, consultations, practitioner qualifications, and patient safety.
2. Greater Focus on Patient Safety
The new Ahpra guidelines introduce stronger expectations around:
- Thorough medical assessments
- Informed consent
- Discussion of risks and alternative options
- Appropriate prescribing practices
- Practitioner training and competency
Our practitioners must ensure treatments are clinically appropriate and that patients understand both benefits and potential complications before proceeding.
3. Tighter Rules Around Telehealth Prescribing
Regulators are increasing scrutiny of “quick” telehealth prescribing models for cosmetic injectables.
Our prescribers are expected to conduct proper assessments and maintain appropriate oversight of patient care and medication supply.
4. Higher Standards for Practitioner Training
The updated guidelines place greater emphasis on practitioner education, supervision, and clinical experience.
This includes clearer expectations around:
- Scope of practice
- Ongoing training
- Clinical competency
- Safe delegation and supervision
Our clinic ensures injectable treatments are performed by appropriately qualified and experienced health professionals.
What This Means for Patients
These reforms are designed to help patients:
- Make informed decisions
- Receive care in safer clinical environments
- Understand risks and expected outcomes
- Access treatment from properly trained practitioners
Patients are encouraged to choose clinics that prioritise medical ethics, transparency, and personalised consultations over sales-driven marketing.
Our Commitment
At our clinic, patient safety, ethical care, and natural-looking outcomes remain our highest priorities. We fully support the updated Australian standards and are committed to:
- Comprehensive consultations
- Evidence-based treatment planning
- Transparent communication
- Ongoing practitioner education
- Compliance with all Ahpra and TGA regulations
